Trump Administration Ready to Tackle Drug Prices
President Donald Trump is expected to sign an executive order that addresses rising drug prices. According to The Hill, the order is expected to be an interim step and not request any drastic changes. The Trump administration is considering directing agencies to pursue value-based purchasing contracts for drugs. Executive orders aren’t laws, but they are used to direct agencies in how to pursue regulatory actions.
Rival to EpiPen Approved
The FDA has approved an emergency epinephrine syringe that will be a lower-cost rival to EpiPen. The pre-filled epinephrine syringes are for emergency use to treat severe allergic reactions; however, at this time the cost of Symjepi has not been announced, reported Reuters. There are other competitors to the EpiPen available, but for years, Mylan has owned more than 90% of the market. Mylan’s generic of its own injector still costs about $300.
No Consensus on Senate Health Bill Deadline
While there has been talk of voting on a Senate healthcare bill by the end of June, there is no consensus regarding whether or not Republicans will meet that deadline. On Thursday, The Washington Post reported that the goal is to bring the bill to a vote on the Senate floor by the end of June. However, a day later, Politico claimed the Senate is likely to miss that deadline. The Senate has just 2 weeks until the Fourth of July recess, yet there are reports of remaining divisions on how to roll back Medicaid expansion and how much to cut from the program.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Survey Results Reveal Potential Factors Slowing the Decline in Cardiovascular Mortality Rate
April 23rd 2024Research indicated that worsened glycemic, blood pressure, and obesity control, as well as increased alcohol consumption, leveled lipid control, and persistent socioeconomic disparities may have contributed to the decelerated cardiovascular mortality decline in recent years.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More